创伤后应激障碍诊断与治疗的最新进展

S. Dowd, P. Janicak
{"title":"创伤后应激障碍诊断与治疗的最新进展","authors":"S. Dowd, P. Janicak","doi":"10.1097/01.IDT.0000325061.73022.3c","DOIUrl":null,"url":null,"abstract":"Dr. Dowd has disclosed that she was the recipient of grant/research support from Astra-Zeneca and Bristol-Meyers Squibb; was/is the recipient of grant/research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; and is a consultant/advisor to Neuronetics. Dr. Janicak has disclosed that he was the recipient of grant research support from Astra-Zeneca and Bristol-Meyers Squibb; is/was the recipient of grant research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; was/is a consultant/advisor to Astra-Zeneca, BristolMeyers Squibb, Janssen, Neuronetics, and Solvay; and is/was a member of the speakers bureau for Abbott, Astra-Zeneca, Bristol-Meyers Squibb, and Pfizer.","PeriodicalId":90307,"journal":{"name":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.IDT.0000325061.73022.3c","citationCount":"2","resultStr":"{\"title\":\"An Update on Diagnostic and Treatment Issues in the Management of Post‐Traumatic Stress Disorder\",\"authors\":\"S. Dowd, P. Janicak\",\"doi\":\"10.1097/01.IDT.0000325061.73022.3c\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dr. Dowd has disclosed that she was the recipient of grant/research support from Astra-Zeneca and Bristol-Meyers Squibb; was/is the recipient of grant/research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; and is a consultant/advisor to Neuronetics. Dr. Janicak has disclosed that he was the recipient of grant research support from Astra-Zeneca and Bristol-Meyers Squibb; is/was the recipient of grant research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; was/is a consultant/advisor to Astra-Zeneca, BristolMeyers Squibb, Janssen, Neuronetics, and Solvay; and is/was a member of the speakers bureau for Abbott, Astra-Zeneca, Bristol-Meyers Squibb, and Pfizer.\",\"PeriodicalId\":90307,\"journal\":{\"name\":\"Psychopharm review : timely reports in psychopharmacology and device-based therapies\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/01.IDT.0000325061.73022.3c\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharm review : timely reports in psychopharmacology and device-based therapies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.IDT.0000325061.73022.3c\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.IDT.0000325061.73022.3c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

Dowd博士透露,她曾获得Astra-Zeneca和bristol - myers Squibb的资助/研究支持;曾经/现在获得了杨森、Neuronetics、赛诺菲-安万特和索尔维的资助/研究支持;他是Neuronetics的顾问。Janicak博士透露,他曾获得Astra-Zeneca和bristol - myers Squibb的研究资助;曾获得杨森、Neuronetics、赛诺菲-安万特和索尔维的研究资助;曾经/现在是Astra-Zeneca, bristol myers Squibb, Janssen, Neuronetics和Solvay的顾问/顾问;曾是雅培、阿斯特拉-利康、百时美施贵宝和辉瑞公司演讲局的成员。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An Update on Diagnostic and Treatment Issues in the Management of Post‐Traumatic Stress Disorder
Dr. Dowd has disclosed that she was the recipient of grant/research support from Astra-Zeneca and Bristol-Meyers Squibb; was/is the recipient of grant/research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; and is a consultant/advisor to Neuronetics. Dr. Janicak has disclosed that he was the recipient of grant research support from Astra-Zeneca and Bristol-Meyers Squibb; is/was the recipient of grant research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; was/is a consultant/advisor to Astra-Zeneca, BristolMeyers Squibb, Janssen, Neuronetics, and Solvay; and is/was a member of the speakers bureau for Abbott, Astra-Zeneca, Bristol-Meyers Squibb, and Pfizer.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信